|
1
|
World Health Organization (WHO), . Global
tuberculosis report 2022[EB/OL]. WHO; Geneva: 2022, https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022October
27–2022
|
|
2
|
Silva DR, Valentini DF Jr, Muller AM, de
Almeida CP and Dalcin Pde T: Pulmonary tuberculosis and lung
cancer: Simultaneous and sequential occurrence. J Brasil Pneumol.
39:484–489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marais BJ, Gie RP, Schaaf HS, Hesseling
AC, Obihara CC, Starke JJ, Enarson DA, Donald PR and Beyers N: The
natural history of childhood intra-thoracic tuberculosis: A
critical review of literature from the pre-chemotherapy era. Int J
Tuberc Lung Dis. 8:392–402. 2004.PubMed/NCBI
|
|
4
|
Kobashi Y, Fukuda M, Nakata M and Oka M:
Coexistence of metastatic lung cancer and pulmonary tuberculosis
diagnosed in the same cavity. Int J Clin Oncol. 10:366–370. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He
QC and Zhou BS: Facts and fiction of the relationship between
preexisting tuberculosis and lung cancer risk: A systematic review.
Int J Cancer. 125:2936–2944. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhatt M, Kant S and Bhaskar R: Pulmonary
tuberculosis as differential diagnosis of lung cancer. South Asian
J Cancer. 1:36–42. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kabashi-Muçaj S, Dedushi-Hoti K, Shatri J,
Pasha F and Dreshaj D: Pulmonary mucinous adenocarcinoma in the
presence of reactivated tuberculosis: A case report. Radiol Case
Rep. 16:3647–3651. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shu CC, Chang SC, Lai YC, Chang CY, Wei YF
and Chen CY: Factors for the early revision of misdiagnosed
tuberculosis to lung cancer: A multicenter study in A
tuberculosis-prevalent area. J Clin Med. 8:7002019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Keikha M and Esfahani BN: The relationship
between tuberculosis and lung cancer. Adv Biomed Res. 7:582018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suárez I, Fünger SM, Kröger S, Rademacher
J, Fätkenheuer G and Rybniker J: The diagnosis and treatment of
tuberculosis. Dtsch Arztebl Int. 116:729–735. 2019.PubMed/NCBI
|
|
11
|
Succony L, Rassl DM, Barker AP, McCaughan
FM and Rintoul RC: Adenocarcinoma spectrum lesions of the lung:
Detection, pathology and treatment strategies. Cancer Treat Rev.
99:1022372021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bloom CI, Graham CM, Berry MP, Rozakeas F,
Redford PS, Wang Y, Xu Z, Wilkinson KA, Wilkinson RJ, Kendrick Y,
et al: Transcriptional blood signatures distinguish pulmonary
tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.
PLoS One. 8:e706302013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang H, Shangguan Y, Wang H, Ji Z, Shao J,
Zhao R, Wang S, Zheng L, Jin X, Huang S, et al: Multicenter
evaluation of the biochip assay for rapid detection of
mycobacterial isolates in smear-positive specimens. Int J Infect
Dis. 81:46–51. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang HY, Bang H, Kim S, Koh WJ and Lee H:
Identification of Mycobacterium species in direct respiratory
specimens using reverse blot hybridisation assay. Int J Tuberc Lung
Dis. 18:1114–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu L, Jiang G, Wang S, Wang C, Li Q, Yu
H, Zhou Y, Zhao B, Huang H, Xing W, et al: Biochip system for rapid
and accurate identification of mycobacterial species from isolates
and sputum. J Clin Microbiol. 48:3654–3660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma J, Fang B and Zhang CS: Targeted
treatment for advanced lung adenocarcinoma guided by mutations in
EGFR exons 19 and 21 in plasma. China Med and Pharm. 14:5–8+46.
2024.(In Chinese).
|
|
17
|
Aisenberg GM, Jacobson K, Chemaly RF,
Rolston KV, Raad II and Safdar A: Extrapulmonary tuberculosis
active infection misdiagnosed as cancer: Mycobacterium tuberculosis
disease in patients at a comprehensive cancer center (2001–2005).
Cancer. 104:2882–2887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jia H, Zhang L and Wang B: The value of
combination analysis of tumor biomarkers for early differentiating
diagnosis of lung cancer and pulmonary tuberculosis. Ann Clin Lab
Sci. 49:645–649. 2019.PubMed/NCBI
|
